InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Ball Titus B.. Director active across 2 companies, notably BeiGene, Ltd.. Cumulatively, 10 disclosures have been recorded. Split: 0 buy · 7 sells. Total volume traded: €98k. History available since 5 June 2024. The latest transaction was filed on 1 September 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Ball Titus B. has 9 filings in total. Across the 9 sampled recent filings between 2024-06-07 and 2026-06-15, sales total EUR 57,811 and the dominant transaction type is sale. He is Principal Accounting Officer at BeOne Medicines Ltd. and BeiGene, Ltd.